Cited by 69Radiomics and Machine Learning in Medical ImagingAI in cancer detectionMedical Imaging Techniques and Applications

Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications

Open access
Preuss, Kiersten, Thach, Nate, Liang, Xiaoying, Baine, Michael, Chen, Justin, Zhang, Chi, Du, Huijing, Yu, Hongfeng +3 more·2022·Cancers

Abstract

As the most lethal major cancer, pancreatic cancer is a global healthcare challenge. Personalized medicine utilizing cutting-edge multi-omics data holds potential for major breakthroughs in tackling this critical problem. Radiomics and deep learning, two trendy quantitative imaging methods that take advantage of data science and modern medical imaging, have shown increasing promise in advancing the precision management of pancreatic cancer via diagnosing of precursor diseases, early detection, accurate diagnosis, and treatment personalization and optimization. Radiomics employs manually-crafted features, while deep learning applies computer-generated automatic features. These two methods aim to mine hidden information in medical images that is missed by conventional radiology and gain insights by systematically comparing the quantitative image information across different patients in order to characterize unique imaging phenotypes. Both methods have been studied and applied in various pancreatic cancer clinical applications. In this review, we begin with an introduction to the clinical problems and the technology. After providing technical overviews of the two methods, this review focuses on the current progress of clinical applications in precancerous lesion diagnosis, pancreatic cancer detection and diagnosis, prognosis prediction, treatment stratification, and radiogenomics. The limitations of current studies and methods are discussed, along with future directions. With better standardization and optimization of the workflow from image acquisition to analysis and with larger and especially prospective high-quality datasets, radiomics and deep learning methods could show real hope in the battle against pancreatic cancer through big data-based high-precision personalization.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers14071654

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There has been a lack of studies in the literature on using MRI radiomics data for the differentiation of pancreatic adenocarcinoma from normal pancreatic tissue.

    “To the best of our knowledge, until now there has been a lack of studies in the literature on using MRI radiomics data for the differentiation of pancreatic adenocarcinoma from normal pancreatic tissue [7,8,9].”

    From Applicability of Radiomics for Differentiation of Pancreatic Adenocarcinoma from Healthy Tissue of Pancreas by Using Magnetic Resonance Imaging and Machine Learning (2025) · cites this paper as [7]

    Section 3.2 (page unavailable) describes CT radiomics studies distinguishing pancreatic cancer from healthy tissue, while the MRI radiomics studies it discusses distinguish cancer from other lesions or chronic pancreatitis. This is consistent with a gap for the specific MRI comparison, but the review does not explicitly establish a literature-wide lack of such studies. (LLM, conf=0.80)

    Experimental — accuracy not yet measured
  • Recent advances include the application of deep learning techniques like CNNs, transformer-based models, and new architectures that focus on handling various types of pancreatic lesions, segmenting multiple organs and tumors, and integrating auxiliary information.

    “Recent advances include the application of deep learning techniques like convolutional neural networks (CNNs), transformer-based models, and new architectures that focus on handling various types of pancreatic lesions, segmenting multiple organs and tumors, and integrating auxiliary information [7,8,9,24,25,26].”

    From Applicability of Radiomics for Differentiation of Pancreatic Adenocarcinoma from Healthy Tissue of Pancreas by Using Magnetic Resonance Imaging and Machine Learning (2025) · cites this paper as [7]

    Section 3.2 (page unavailable) describes CNNs for different pancreatic lesions and a deep-learning approach that segments abdominal organs before detecting pancreatic cancer. Section 3.1 describes combining radiomic features with deep-learning models, supporting the integration of auxiliary information. The reviewed passages do not establish the claim about transformer-based models, and the cited multi-organ approach detects rather than segments tumors. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Few reviews discuss the latest developments in AI for pancreatic cancer diagnosis using cross-sectional imaging techniques, with most focusing on CT.

    “Few reviews discuss the latest developments in AI for pancreatic cancer diagnosis using cross-sectional imaging techniques, with most focusing on CT [7,8,9,25,26,27].”

    From Applicability of Radiomics for Differentiation of Pancreatic Adenocarcinoma from Healthy Tissue of Pancreas by Using Magnetic Resonance Imaging and Machine Learning (2025) · cites this paper as [7]

    The Introduction (page unavailable) identifies a gap in comprehensive reviews of pancreatic-cancer radiomics and deep learning, and Section 3.2 reviews imaging-based detection and diagnosis. Section 2.1 says CT is the most widely used imaging modality, but the paper does not say that most *reviews* focus on CT; that part of the citing sentence is unsupported. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 132 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [76]Zhang Z. Li S. Wang Z. Lu Y. A Novel and Efficient Tumor Detection Framework for Pancreatic Cancer via CT Images Proceedings of the 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) Montreal, QC, Canada 30 October 2020 33018193

Cited by

Sorted by citations

Authors
Preuss, K., Thach, N., Liang, X., Baine, M., Chen, J., Zhang, C., Du, H., Yu, H., Lin, C., Hollingsworth, M. A., & Zheng, D.
Affiliations
  • University of Nebraska–Lincoln (US)
  • Mayo Clinic (US)
  • University of Nebraska Medical Center (US)
  • University of Rochester Medicine (US)
Corresponding author
Zheng, Dandan
Venue
Cancers
Publisher
MDPI AG
Published
2022-03-24
Volume
14
Issue
7
Pages
1654
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4220797967
Cited by
69
References
132
Citations by year
2026: 5 · 2025: 25 · 2024: 12 · 2023: 20 · 2022: 7
FWCI
2.72
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lincoln (University of Nebraska) (submittedVersion, cc-by)
Funders
National Institutes of Health (2P50CA127297-06A1)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
pancreatic cancer, radiomics, deep learning, quantitative imaging, personalized medicine, radiogenomics, precancerous lesions, early detection, outcome prediction, treatment stratification, imaging phenotypes, multi-omics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review